Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

H Christoph Westphal


  • President And Ceo at Flex Pharma, Inc. (FLKS), 2016-01-25
  • Executive Chairman at Verastem, Inc. (VSTM), 2015-07-01
  • Large Shareholder, Director at Ovascience, Inc. (OVAS), 2014-03-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
FLKS $12.01 927 Large Shareholder, Officer, Director 3,925,248 2015-12-14 Filing
FLKS $12.02 907 Large Shareholder, Officer, Director 3,924,321 2015-12-07 Filing
FLKS $12.32 887 Large Shareholder, Officer, Director 3,923,414 2015-11-30 Filing
FLKS $11.39 971 Large Shareholder, Officer, Director 3,922,527 2015-11-23 Filing
FLKS $10.78 1,001 Large Shareholder, Officer, Director 3,921,556 2015-11-16 Filing

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!